Overcome challenges in high-throughput 3D imaging

Optimizing high-content screening tools for physiologically-relevant 3D in vitro models

Elodie Vandenhaute, Study Director | HCS Pharma
Zied Souguir, Senior Scientist | HCS Pharma
Dan O’Connor, North America Bioimaging Director | Molecular Devices

Watch our webinar with HCS Pharma, a biotechnology start-up company based in France, as we discuss the biological characterization of cells in 3D matrices for liver, brain and adipose tissues, and cancer modeling, using BIOMIMESYS® hydroscaffold technology. We also discuss high-content screening solutions for examining 3D in vitro models.

Key learning objectives:

• Describe the differentiating factors between different 3D cell culture systems
• Utilizing a relevant 3D cell culture platform for liver, brain, adipose tissue, and disease modeling (human cells)
• Optimizing setup of a high-content screening platform for 3D in vitro models

We will email you the link to our on-demand webinar shortly!